Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 224,884,437 papers from all fields of science
Search
Sign In
Create Free Account
nitisinone
Known as:
Nitisinonum
, 2-(alpha,alpha,alpha-Trifluoro-2-nitro-P-tuluoyl)-1,3-cyclohexanedione
, nitisinone [Chemical/Ingredient]
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
6 relations
Broader (3)
Cyclohexanones
Enzyme Inhibitors
Nitrobenzoates
Drug Allergy
Tyrosinemias
nitisinone 4 MG/ML Oral Suspension [Orfadin]
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
Asymptomatic Corneal Keratopathy Secondary to Hypertyrosinaemia Following Low Dose Nitisinone and a Literature Review of Tyrosine Keratopathy in Alkaptonuria.
M. Khedr
,
S. Judd
,
+6 authors
Lakshminarayan R. Ranganath
JIMD Reports
2018
Corpus ID: 9511854
Nitisinone, although unapproved for use in alkaptonuria (AKU), is currently the only homogentisic acid lowering therapy with a…
Expand
Review
2017
Review
2017
Nitisinone: A review
Çiğdem Aktuğlu-Zeybek
,
T. Zubarioglu
2017
Corpus ID: 51764545
php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org…
Expand
2017
2017
Corneal Pseudodendritic Lesions Masquerading as Herpetic Keratitis in a Patient With Tyrosinemia Type I
Duygu Gulmez Sevim
,
K. Gumus
,
H. Cavanagh
Eye & contact lens
2017
Corpus ID: 7649894
Objective: To describe the clinical findings of a patient with tyrosinemia type I with noncompliance to a protein-restricted diet…
Expand
2015
2015
Cost-Consequence Analysis of Nitisinone for Treatment of Tyrosinemia Type I.
M. Simoncelli
,
J. Samson
,
+4 authors
S. Perreault
The Canadian Journal of Hospital Pharmacy
2015
Corpus ID: 38272518
BACKGROUND Tyrosinemia type I is a rare but severe genetic metabolic disorder. Nitisinone combined with a diet low in tyrosine…
Expand
2013
2013
Confocal Microscopy of Corneal Crystals in a Patient With Hereditary Tyrosinemia Type I, Treated With NTBC
Pieter-Paul Schauwvlieghe
,
J. Jaeken
,
P. Kestelyn
,
I. Claerhout
Cornea
2013
Corpus ID: 205667681
Purpose: To describe the confocal microscopic findings in a patient with hereditary tyrosinemia type I (HT-I) treated with 2-(2…
Expand
2005
2005
Nitrosation of sugar oximes: preparation of 2-glycosyl-1-hydroxydiazene-2-oxides.
J. Brand
,
T. Huhn
,
U. Groth
,
J. C. Jochims
Chemistry
2005
Corpus ID: 16759896
Oximes of glucose, xylose, lactose, fructose, and mannose have been prepared. Nitrosation of the oximes of glucose, xylose, and…
Expand
2003
2003
Extensive changes in liver gene expression induced by hereditary tyrosinemia type I are not normalized by treatment with 2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione (NTBC).
Marjanka C Luijerink
,
S. M. Jacobs
,
+4 authors
I. E. van den Berg
Journal of Hepatology
2003
Corpus ID: 29338272
2002
2002
Corneal opacities associated with NTBC treatment.
Saadullah Ahmad
,
J. Teckman
,
G. Lueder
American journal of ophthalmology-glaucoma
2002
Corpus ID: 23101595
1999
1999
Determination of 2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione in plasma by direct injection into a coupled column liquid chromatographic system.
M. Bielenstein
,
L. Astner
,
S. Ekberg
Journal of Chromatography B: Biomedical Sciences…
1999
Corpus ID: 19971526
1999
1999
Sensitive spectrofluorimetric determination of ruthenium at nanotrace levels using 2-(α-pyridyl) thioquinaldinamide [PTQA]
B. K. Pal
,
M. Sahedur Rahman
1999
Corpus ID: 22182013
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE